Search results
COVID summer guide: How to navigate symptoms, variants and vaccines this season
Yahoo Life· 11 hours ago“The summer wave is coming, and the vaccine does offer quite a bit of protection against the [FliRT]...
KP.3 is the dominant COVID-19 variant in the US: Latest on test positivity, deaths, symptoms
USA Today· 12 hours agoCases of the latest COVID-19 variant, also known as KP.3, are on the rise in the United States....
US FDA expands GSK's RSV vaccine approval to adults aged 50 to 59
Reuters via Yahoo News· 6 days agoThe shot, branded Arexvy, and vaccines from rivals Pfizer and Moderna are already approved for...
Results are looking promising for a combined COVID and flu vaccine. Here’s how it could benefit...
The Conversation· 2 hours agoEarlier this week, Moderna announced positive results for its phase 3 clinical trial of a combined vaccine against COVID and influenza. Combination vaccines
Another COVID vaccine? Yes, and here’s why
Denver Post· 3 days agoWhen compared against results from the original shot, the benefit of the new shot may seem modest. That’s because the original vaccines were given to a...
Pfizer Provides Update on Phase 3 Study of Investigational Gene Therapy for Ambulatory Boys with...
Morningstar· 1 day agoPfizer Inc. (NYSE: PFE) today announced that CIFFREO, a Phase 3 global, multicenter, randomized, double-blind, placebo-controlled study evaluating the investigational mini-dystrophin ...
Pfizer's Paxlovid fails as 15-day treatment for long COVID, study finds
FOX Business· 5 days agoA 15-day course of Pfizer's COVID-19 antiviral treatment Paxlovid did not relieve symptoms of long...
COVID-flu combo vaccine shows ‘positive’ results in phase 3 trials, Moderna says: A 'two-for' option
Fox News via Yahoo News· 3 days agoModerna, which is developing a combination COVID-flu vaccine, announced on Monday that in phase 3...
FDA gives nod to RSV vaccine for people in their 50s
Medical Xpress· 3 days agoDrugmaker GSK's Arexvy vaccine, as well as vaccines from Pfizer and Moderna, are already approved for use in adults 60 and older, since ...
Moderna price target raised at Oppenheimer after RSV vaccine approval By Investing.com
Investing.com· 2 days agoModerna price target raised at Oppenheimer after RSV vaccine approval